Search - tctmd.com

Displaying 81 - 100 of 164

Sort: Relevancy | Date

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Shelley Wood

April 01, 2022

News Opinion CV Team Dispatch

April 2022 News Roundup

L.A. McKeown

April 01, 2022

News Daily News

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Michael O'Riordan

March 01, 2022

News Daily News

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Michael O'Riordan

February 10, 2022

News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Michael O'Riordan

January 17, 2022

News Opinion CV Team Dispatch

January 2022 News Roundup

L.A. McKeown

January 01, 2022

News Daily News

New Revascularization Guidelines Plug Radial Access, Staged PCI, and Shorter DAPT

Michael O'Riordan

December 09, 2021

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Shelley Wood

November 08, 2021

News Daily News

CVD Risk ‘Underappreciated’ After Adverse Pregnancy Outcomes

L.A. McKeown

November 01, 2021

News Daily News

Heterozygous FH Diagnosed Late, Remains Undertreated

Michael O'Riordan

September 13, 2021

News Daily News

Could an App Replace Statin Prescribing by Doctors?

Michael O'Riordan

September 08, 2021

News Conference News ESC 2021

No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER

Michael O'Riordan

September 02, 2021

News Daily News

Food Insecurity Common Among Patients With ASCVD

Michael O'Riordan

August 18, 2021

News Opinion CV Team Dispatch

July/August 2021 News Roundup

L.A. McKeown

August 01, 2021

News Daily News

Statin Decisions Gain From Scoring of Coronary Artery Calcium: MESA

Yael L. Maxwell

July 21, 2021

News Daily News

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

Michael O'Riordan

June 16, 2021

News Conference News EAS 2021

For High-Risk Patients Getting Evolocumab in Europe, Other Meds Fall Short

Michael O'Riordan

June 03, 2021

News Conference News ACC 2021

High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE

Michael O'Riordan

May 15, 2021

News Daily News

In Female Veterans With Early ASCVD, Secondary Prevention Falls Short

Michael O'Riordan

April 21, 2021

News Daily News

Mobile Tech May Boost CAD Secondary Prevention for Older Adults

L.A. McKeown

April 07, 2021

Advertisement

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

April 2022 News Roundup

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

January 2022 News Roundup

New Revascularization Guidelines Plug Radial Access, Staged PCI, and Shorter DAPT

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

CVD Risk ‘Underappreciated’ After Adverse Pregnancy Outcomes

Heterozygous FH Diagnosed Late, Remains Undertreated

Could an App Replace Statin Prescribing by Doctors?

No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER

Food Insecurity Common Among Patients With ASCVD

July/August 2021 News Roundup

Statin Decisions Gain From Scoring of Coronary Artery Calcium: MESA

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

For High-Risk Patients Getting Evolocumab in Europe, Other Meds Fall Short

High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE

In Female Veterans With Early ASCVD, Secondary Prevention Falls Short

Mobile Tech May Boost CAD Secondary Prevention for Older Adults

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content